Skip to content
VRTX Vertex Pharmaceuticals Inc NASDAQ
420.58 USD 0.78% +3.26
OPEN 419.48
PREV CLOSE 417.32
DAY RANGE 420.67 - 415.06
VOLUME 168.8K
AVG. VOLUME 896.4K
52 WEEK RANGE 448.40 - 309.43
Interactive Brokers Logotype

Buy VRTX stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 107.8B
Enterprise value 97.4B
Trailing pe 30.044636
Forward pe 22.742235
Peg ratio 22.742235
Price to sales ttm 10.922576
Price to book mrq 6.1170883
Enterprise to revenue 9.868
Enterprise to ebitda 21.753

Financials

Fiscal year ends 2023-12-31
Most recent quarter 2023-12-31
Profit margin 0.36676
Operating margin 0.37971002
Return on assets ttm 0.13171
Return on equity ttm 0.22986999
Income statement
Revenue ttm 9.9B
Revenue per share ttm 38.297
Quarterly revenue growth 0.093
Gross profit ttm 8.6B
Ebitda 5.1B
Net income to common ttm 3.6B
Diluted eps ttm 13.89
Quarterly earnings growth yoy 0.183
Balance sheet
Total cash mrq 11.2B
Total cash per share mrq 43.43
Total debt mrq 808.4M
Total debt to equity mrq 4.598
Current ratio mrq 3.987
Book value per share mrq 68.222
Cash flow
Operating cash flow ttm 3.5B
Levered free cash flow ttm 3.5B

Stock statistics

Shares outstanding 258.3M
Float shares 257.4M
Avg 10 volume 1M
Avg 90 volume 1M
Shares short 4.1M
Short ratio 2.57
Short percent of shares outstanding 0.015700001
Percent held by insiders 0.0010800001
Percent held by institutions 0.95783997

Stock price summary

Fifty two week low 310.9
Fifty two week high 448.4
Fifty two week change 25.758
Beta 0.351
Day 50 ma 423.0006
Day 200 ma 377.61404

Dividends and splits

Last split factor 2-for-1 split
Last split date 2000-08-24

Vertex Pharmaceuticals (VRTX) company profile

Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) is a biotechnology company. The company discovers, develops, manufactures, and commercializes small molecule drugs for patients with serious diseases. The firm solutions treat cystic fibrosis, infectious diseases, and autoimmune diseases.